Paper Details

  1. Home
  2. Paper Details

The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder.

Author: AthanasiouMaria, CroftHarry A, GallipoliSusan, KajdaszDaniel K, LiebowitzMichael, ReedCarol R, WhalenHeidi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Vilazodone, a selective serotonin reuptake inhibitor and 5-HT1A receptor partial agonist, is generally well-tolerated in the treatment of major depressive disorder (MDD), both in the short and long term.
Paper Details　
Original Abstract of the Article :
Label="OBJECTIVE" NlmCategory="OBJECTIVE">Vilazodone is a selective serotonin reuptake inhibitor and 5-HT<sub>1A</sub> receptor partial agonist approved for the treatment of major depressive disorder (MDD). This report summarizes the safety and tolerability of vilazodone 40 mg/day during short- and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044546/

データ提供：米国国立医学図書館（NLM）

Vilazodone: A Novel Antidepressant with a Favorable Safety Profile

Major depressive disorder (MDD) is a serious mental health condition that can have a profound impact on an individual's life. Imagine a desert traveler facing a challenging journey, struggling with the weight of sadness and despair. This report explores the safety and tolerability of vilazodone, a novel antidepressant, in the treatment of MDD.

Vilazodone: A Potential Oasis in the Desert of Depression

The report summarizes the safety and tolerability of vilazodone 40 mg/day during both short-term and long-term treatment of MDD. The findings suggest that vilazodone has a favorable safety profile, with minimal side effects. It's like discovering a hidden oasis in the desert, offering a safe and effective haven for those struggling with depression.

Navigating the Desert of Depression: Finding a Path to Wellness

This report provides valuable information for healthcare professionals and patients seeking a safe and effective treatment for MDD. While further research is needed to fully understand its long-term effects, vilazodone's favorable safety profile suggests it could be a promising option for managing depression.

Dr.Camel's Conclusion

This report highlights the promising safety profile of vilazodone, a novel antidepressant for the treatment of MDD. Its favorable safety profile suggests it could offer a valuable option for patients seeking relief from depression, providing a potential oasis in the desert of mental health challenges.

Date :
  1. Date Completed n.d.
  2. Date Revised 2019-11-20
Further Info :

Pubmed ID

27738360

DOI: Digital Object Identifier

PMC5044546

Related Literature

Article Analysis
・Side Effects of vilazodone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.